Initial public offering of Pexip Holding ASA (NO) on Oslo Stock Exchange – NOK 2.4 billion TMT Initial public offering of Pexip Holding ASA (NO) on Oslo Stock Exchange – NOK 2.4 billion
Sale of Evondos (FI) by Serendipity Partners (NO) — Amount not disclosed Healthcare Sale of Evondos (FI) by Serendipity Partners (NO) — Amount not disclosed
Acquisition of a majority stake in Eleda Infra Services Group (SE) by Altor Fund V (SE) — Amount not disclosed Business Services Acquisition of a majority stake in Eleda Infra Services Group (SE) by Altor Fund V (SE) — Amount not disclosed
Directed new share issue in Oncopeptides AB (SE) — SEK 1.4 billion Healthcare Directed new share issue in Oncopeptides AB (SE) — SEK 1.4 billion
Directed new share issue in BerGenBio´s ASA (NO) — NOK 500 million Healthcare Directed new share issue in BerGenBio´s ASA (NO) — NOK 500 million
Acquisition of Saber Interactive Inc. (US) by Embracer Group (SE) — USD 525 million TMT Acquisition of Saber Interactive Inc. (US) by Embracer Group (SE) — USD 525 million
Directed new share issue in Nordic Aquafarms AS (NO) – NOK 88 million Business Services Directed new share issue in Nordic Aquafarms AS (NO) – NOK 88 million
Directed share issue in NCAB Group AB (SE) — SEK 287 million Industrials Directed share issue in NCAB Group AB (SE) — SEK 287 million
Rights issue in Bambuser AB (SE) — SEK 101 million TMT Rights issue in Bambuser AB (SE) — SEK 101 million
Directed new share issue in Enad Global 7 AB (SE) – SEK 119 million TMT Directed new share issue in Enad Global 7 AB (SE) – SEK 119 million
Directed share issue in Faron Pharmaceuticals Oy (FI) – EUR 14.0 million Healthcare Directed share issue in Faron Pharmaceuticals Oy (FI) – EUR 14.0 million
Listing of Cellink AB (SE) on Nasdaq Stockholm Healthcare Listing of Cellink AB (SE) on Nasdaq Stockholm